Prostin Injection, Solution
NDC Package 0009-3169-06

11-digit billing NDC: 00009316906 · Billing unit: ML · 5 ML per package

Package Information

Prostin (alprostadil) injection is pROSTIN VR PEDIATRIC Sterile Solution is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. This formulation utilizes a injection, solution delivery system. Marketed by Pharmacia & Upjohn Company Llc, this product is identified by NDC 0009-3169 and is authorized under FDA application NDA018484.

Identification & Billing

NDC Package Code
0009-3169-06
Package Description
5 AMPULE in 1 PACKAGE / 1 mL in 1 AMPULE (0009-3169-01)
Product Code
11-Digit Billing Format
00009316906
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
5 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Prostin Vr Pediatric
Non-Proprietary Name
Alprostadil
Substance Name
Alprostadil
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intravascular - Administration within a vessel or vessels.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Usage Information
PROSTIN VR PEDIATRIC Sterile Solution is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. Such congenital heart defects include pulmonary atresia, pulmonary stenosis, tricuspid atresia, tetralogy of Fallot, interruption of the aortic arch, coarctation of the aorta, or transposition of the great vessels with or without other defects.In infants with restricted pulmonary blood flow, the increase in blood oxygenation is inversely proportional to pretreatment pO2 values; that is, patients with low pO2 values respond best, and patients with pO2 values of 40 torr or more usually have little response.PROSTIN VR PEDIATRIC should be administered only by trained personnel in facilities that provide pediatric intensive care.

Regulatory & Marketing

Labeler Name
Pharmacia & Upjohn Company Llc
Product Type
Human Prescription Drug
FDA Application #
NDA018484
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-16-1981
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

Source: PDAC
INJECTION, ALPROSTADIL, 1.25 MCG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)
HCPCS Dosage 1.25 MCG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0009-3169-06 identifies a specific commercial package of 5 ampule in 1 package / 1 ml in 1 ampule (0009-3169-01) of Prostin Vr Pediatric, a human prescription drug labeled by Pharmacia & Upjohn Company Llc. This product is billed per "ML" milliliter and contains an estimated amount of 5 billable units per package. This injection, solution is formulated for intravascular; intravenous use and contains alprostadil as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pharmacia & Upjohn Company Llc on October 16, 1981. The current certification is valid through December 31, 2027.

How is this Pharmacia & Upjohn Company Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00009316906. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0009-3169-06
11-Digit CMS (5-4-2)
00009-3169-06

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.